Related Experiment Video
Updated: Feb 9, 2026

Modeling Hepatitis B Virus Infection in Non-Hepatic 293T-NE-3NRs Cells
Published on: June 5, 2020
Smc5/6 Antagonism by HBx Is an Evolutionarily Conserved Function of Hepatitis B Virus Infection in Mammals
Fabien Abdul1, Fabien Filleton2, Laetitia Gerossier3
1Department of Microbiology and Molecular Medicine, University Medical Centre (CMU)/University of Geneva, Geneva, Switzerland.
Insights
The Smc5/6 complex acts as a defense against hepatitis B virus (HBV) in mammals. Viral HBx proteins evolved to degrade Smc5/6, indicating a conserved virus-host evolutionary battle.
Area of Science:
- Virology
- Genetics
- Evolutionary Biology
Background:
- Chronic hepatitis B virus (HBV) infection causes significant liver disease and cancer.
- The Smc5/6 complex, crucial for genome maintenance, restricts human HBV.
- HBV's HBx protein counteracts Smc5/6 by promoting its degradation.
Purpose of the Study:
- To investigate the evolutionary conservation and functional importance of Smc5/6 antiviral activity against hepadnaviruses.
- To determine if HBx proteins from diverse hepadnaviruses can antagonize the Smc5/6 complex.
Main Methods:
- Phylogenetic and positive selection analyses of Smc5/6 complex subunits.
- Functional testing of HBx proteins from six divergent hepadnaviruses.
- Infection of primary human hepatocytes with HBx-deficient HBV.
Main Results:
- Smc5/6 subunits are conserved in mammals; Smc6 shows signs of adaptive evolution ('arms race').
- Divergent HBx proteins efficiently degraded mammalian Smc5/6 complexes, irrespective of host species or selected sites.
- All tested HBx proteins rescued replication of HBx-deficient HBV in human hepatocytes.
Conclusions:
- Smc5/6 inactivation by HBx is an evolutionarily conserved mechanism against hepadnaviruses in mammals.
- Smc5/6's antiviral role against HBV is significant and has shaped host-virus co-evolution.
- Smc5/6 may act as a restriction factor against other, yet undiscovered viruses.
Abstract:
Chronic infection with hepatitis B virus (HBV) is a major cause of liver disease and cancer in humans. HBVs (family Hepadnaviridae) have been associated with mammals for millions of years. Recently, the Smc5/6 complex, known for its essential housekeeping functions in genome maintenance, was identified as an antiviral restriction factor of human HBV. The virus has, however, evolved to counteract this defense mechanism by degrading the complex via its regulatory HBx protein. Whether the antiviral activity of the Smc5/6 complex against hepadnaviruses is an important and evolutionarily conserved function is unknown. In this study, we used an evolutionary and functional approach to address this question. We first performed phylogenetic and positive selection analyses of the Smc5/6 complex subunits and found that they have been conserved in primates and mammals. Yet, Smc6 showed marks of adaptive evolution, potentially reminiscent of a virus-host "arms race." We then functionally tested the HBx proteins from six divergent hepadnaviruses naturally infecting primates, rodents, and bats. We demonstrate that despite little sequence homology, these HBx proteins efficiently degraded mammalian Smc5/6 complexes, independently of the host species and of the sites under positive selection. Importantly, all HBx proteins also rescued the replication of an HBx-deficient HBV in primary human hepatocytes. These findings point to an evolutionarily conserved requirement for Smc5/6 inactivation by HBx, showing that Smc5/6 antiviral activity has been an important defense mechanism against hepadnaviruses in mammals. It will be interesting to investigate whether Smc5/6 may further be a restriction factor of other, yet-unidentified viruses that may have driven some of its adaptation.IMPORTANCE Infection with hepatitis B virus (HBV) led to 887,000 human deaths in 2015. HBV has been coevolving with mammals for millions of years. Recently, the Smc5/6 complex, which has essential housekeeping functions, was identified as a restriction factor of human HBV antagonized by the regulatory HBx protein. Here we address whether the antiviral activity of Smc5/6 is an important evolutionarily conserved function. We found that all six subunits of Smc5/6 have been conserved in primates, with only Smc6 showing signatures of an "evolutionary arms race." Using evolution-guided functional analyses that included infections of primary human hepatocytes, we demonstrated that HBx proteins from very divergent mammalian HBVs could all efficiently antagonize Smc5/6, independently of the host species and sites under positive selection. These findings show that Smc5/6 antiviral activity against HBV is an important function in mammals. They also raise the intriguing possibility that Smc5/6 may restrict other, yet-unidentified viruses.
Related Concept Videos
What is Conservation Biology?
Conserved Binding Sites
Binding sites are often located in large pockets, and if their location on a protein’s surface is unknown, it can be predicted using various approaches. The energetic method computationally...
Conservation of Small Populations
Agonism and Antagonism: Quantification
To quantify these effects, researchers use a dose-response curve, which provides valuable information about the potency and efficacy of a drug. Potency refers to...
Conservation of Protein Domains Over Different Proteins
A limited set of protein domains often duplicate and recombine during evolution. These domains can be organized in different combinations to...
Combined Effects of Drugs: Antagonism
The most common type is receptor antagonism, where one drug acts as an antagonist to block the effects of another drug by...

